We are live on
!
Find out more
Haemonetics
177 hedge funds and large institutions have $1.5B invested in Haemonetics in 2016 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 78 increasing their positions, 48 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
63% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 48
33% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 24
4% more funds holding
Funds holding: 170 → 177 (+7)
0.39% more ownership
Funds ownership: 100.83% → 101.22% (+0.39%)
16% less capital invested
Capital invested by funds: $1.78B → $1.5B (-$282M)
Holders
177
Holders Change
+7
Holders Change %
+4.12%
% of All Funds
4.72%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
32
Increased
78
Reduced
48
Closed
24
Calls
$249K
Puts
–
Net Calls
+$249K
Net Calls Change
+$249K
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.4M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$18.8M |
| 3 |
RCM
Rutabaga Capital Management
Boston,
Massachusetts
|
+$18.6M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$16.9M |
| 5 |
Renaissance Technologies
New York
|
+$15.1M |
